Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01363141 · ClinicalTrials.gov registry record · NA
Effect of a Low Advanced Glycation End Products (AGE) Diet in the Metabolic Syndrome
A NA study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 383
- Enrollment target
NCT01363141 is a NA study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 383 participants.
The verdict
NCT01363141, a NA study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 383 participants
- Enrollment target
Study Summary
The investigators have previously demonstrated that Advanced Glycation End products (AGEs) are associated with several chronic diseases in humans and that blood AGE levels can be significantly reduced by simply changing the way food is cooked. This is an interventional-randomized study in which we are trying to determine whether a diet low in AGE followed for 1 year can effectively reduce circulating AGE levels as well as markers of the metabolic syndrome in a group of patients with these abnormal markers.
Interventions
- OTHER Regular AGE Diet
- OTHER Low AGE Diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 383 participants |
| Start Date | 2010-12 |
| Est. Completion | 2014-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01363141
The ClinicalTrials.gov registry entry for NCT01363141 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 383 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Regular AGE Diet is the first listed.
NCT01363141 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01363141 about?
NCT01363141 is a clinical study titled "Effect of a Low Advanced Glycation End Products (AGE) Diet in the Metabolic Syndrome". The investigators have previously demonstrated that Advanced Glycation End products (AGEs) are associated with several chronic diseases in humans and that blood AGE levels can be significantly reduced by simply changing the way food is cooked. This is an interventional-randomized study in which we ...
What is the current status of trial NCT01363141?
This trial is currently completed. It is a NA study. The enrollment target is 383 participants. The study started on 2010-12. Estimated completion is 2014-12.
What interventions are being tested in trial NCT01363141?
The interventions under investigation include: Regular AGE Diet (OTHER), Low AGE Diet (OTHER).
Who is sponsoring clinical trial NCT01363141?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.